These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8103226)
1. Power analysis for correlation of plasma level and clinical data. Davis JM; Wang Z Psychopharmacol Ser; 1993; 10():253-64. PubMed ID: 8103226 [No Abstract] [Full Text] [Related]
3. Placebo washout in trials of antipsychotic drugs. Volavka J; Cooper TB; Laska EM; Meisner M Schizophr Bull; 1996; 22(4):567-76. PubMed ID: 8938911 [TBL] [Abstract][Full Text] [Related]
4. [Clinical aspects and significance of measuring concentrations of neuroleptics and antidepressants in the blood]. Cheshkova E; Shvestka Ia Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):573-6. PubMed ID: 2872761 [TBL] [Abstract][Full Text] [Related]
5. [Correlation between plasma concentration and clinical effect of neuroleptics and antidepressants]. Modestin J; Petrin A Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):11-21. PubMed ID: 2561 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics of the interaction of neuroleptics and antidepressants with plasma proteins (review of the literature)]. Bender KI; Kupchikov VV; Lutsevich AN Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):116-24. PubMed ID: 1686128 [No Abstract] [Full Text] [Related]
7. Stability of Antidepressants and Antipsychotics in Gel Separator Tubes. Berg JA; Schjøtt J; Carstensen K; Fossan KO; Skrede S; Bjånes TK; Serkland TT; Riedel B Ther Drug Monit; 2019 Apr; 41(2):249-250. PubMed ID: 30883518 [No Abstract] [Full Text] [Related]
8. Competition for plasma protein binding sites between phenothiazine tranquilizers and iminodibenzyl antidepressants. Sharples D J Pharm Pharmacol; 1975 May; 27(5):379-81. PubMed ID: 239146 [No Abstract] [Full Text] [Related]
9. Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging. Gründer G; Hiemke C; Paulzen M; Veselinovic T; Vernaleken I Pharmacopsychiatry; 2011 Sep; 44(6):236-48. PubMed ID: 21959785 [TBL] [Abstract][Full Text] [Related]
10. Drug-placebo difference: in antidepressant drug trials could be 50% greater than previously believed. Rihmer Z Neuropsychopharmacol Hung; 2007 Mar; 9(1):35-7. PubMed ID: 17879563 [TBL] [Abstract][Full Text] [Related]
11. Drug-resistance phenomena in major psychoses: their discrimination and causal mechanisms. Altamura AC Clin Neuropharmacol; 1990; 13 Suppl 1():S1-15. PubMed ID: 1974169 [TBL] [Abstract][Full Text] [Related]
12. [Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control]. Broich K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):541-7. PubMed ID: 15887064 [TBL] [Abstract][Full Text] [Related]
13. A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia. Gharabawi GM; Bossie CA; Pandina GJ; Kujawa MJ; Greenspan AJ; Zhu Y J Clin Psychiatry; 2007 Feb; 68(2):333; author reply 334. PubMed ID: 17335334 [No Abstract] [Full Text] [Related]
14. Antidepressant response and plasma concentrations of bupropion. Preskorn SH J Clin Psychiatry; 1983 May; 44(5 Pt 2):137-9. PubMed ID: 6406443 [TBL] [Abstract][Full Text] [Related]
15. [Determination of drug concentrations in body fluid; possibilities and limitations. II. Determination of plasma levels as a part of individual patient treatment]. Ariëns EJ; Simonis AM Ned Tijdschr Geneeskd; 1980 Jul; 124(29):1201-12. PubMed ID: 6106163 [No Abstract] [Full Text] [Related]
17. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics. Dahl ML; Sjöqvist F Ther Drug Monit; 2000 Feb; 22(1):114-7. PubMed ID: 10688272 [TBL] [Abstract][Full Text] [Related]
18. Some of the problems and difficulties associated with clinical studies of antidepressant agents. Jenner FA Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):199S-207S. PubMed ID: 334224 [No Abstract] [Full Text] [Related]
19. Active placebos in antidepressant trials. Moncrieff J; Wessely S Br J Psychiatry; 1998 Jul; 173():88. PubMed ID: 9850217 [No Abstract] [Full Text] [Related]
20. Placebo group needed for interpretation of combination trial. El-Mallakh RS; Kaur G; Lippman S Am J Psychiatry; 2010 Aug; 167(8):996; author reply 996-7. PubMed ID: 20693473 [No Abstract] [Full Text] [Related] [Next] [New Search]